These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 6163303

  • 1. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O, Johansson BB, Svennerholm L.
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [Abstract] [Full Text] [Related]

  • 2. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D, Pullar IA, Mawdsley C, Kinloch N, Yates CM.
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [Abstract] [Full Text] [Related]

  • 3. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ, Bird ED, McEntee WJ.
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [Abstract] [Full Text] [Related]

  • 4. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R, Ekstedt J, Anggård E.
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007 Jul; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Jul; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 9. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L, Wiberg A, Asberg M, Träskman L, Sjöstrand L, Thorén P, Bertilsson L, Tybring G.
    Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
    [Abstract] [Full Text] [Related]

  • 10. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G.
    Prog Biochem Pharmacol; 1980 Feb; 16():133-40. PubMed ID: 6160594
    [Abstract] [Full Text] [Related]

  • 11. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
    Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA.
    J Neurochem; 1984 Mar; 42(3):833-7. PubMed ID: 6198473
    [Abstract] [Full Text] [Related]

  • 12. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 13. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T, Fujimoto A, Ohshimo T, Yamamoto M, Kugoh T, Akiyama K, Otsuki S.
    No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
    [No Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ, Walsh FX, Bird ED, Levy HL.
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [Abstract] [Full Text] [Related]

  • 15. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
    Alfredsson G, Wiesel FA, Tylec A.
    Biol Psychiatry; 1988 Apr 01; 23(7):689-97. PubMed ID: 2453224
    [Abstract] [Full Text] [Related]

  • 16. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN.
    J Neurol Neurosurg Psychiatry; 1984 May 01; 47(5):481-4. PubMed ID: 6204017
    [Abstract] [Full Text] [Related]

  • 17. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K.
    Neurology; 1979 Aug 01; 29(8):1157-61. PubMed ID: 37460
    [Abstract] [Full Text] [Related]

  • 18. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L, Asberg M, Bertilsson L, Sjöstrand L.
    Arch Gen Psychiatry; 1981 Jun 01; 38(6):631-6. PubMed ID: 6166274
    [Abstract] [Full Text] [Related]

  • 19. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
    Nordin C.
    Acta Psychiatr Scand; 1988 Dec 01; 78(6):720-9. PubMed ID: 2464903
    [Abstract] [Full Text] [Related]

  • 20. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
    Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR.
    Biol Psychiatry; 2004 Apr 01; 55(7):739-44. PubMed ID: 15039003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.